In the BioHarmony Drug Report Database
Cefamandole nafate
Mandol (cefamandole nafate) is a small molecule pharmaceutical. Cefamandole nafate was first approved as Mandol on 1982-01-01. It is used to treat bacterial pneumonia, bacterial skin diseases, escherichia coli infections, haemophilus infections, and infectious bone diseases amongst others in the USA.
Trade Name
|
Mandol |
|---|---|
Common Name
|
cefamandole nafate |
ChEMBL ID
|
CHEMBL1618 |
Indication
|
bacterial pneumonia, bacterial skin diseases, escherichia coli infections, haemophilus infections, infectious bone diseases, klebsiella infections, proteus infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections |
Drug Class
|
Cephalosporins |
Image (chem structure or protein)